Items where Author is "Poursadeghfard, M."

(2025) Investigating treatment alternatives for fingolimod in patients with multiple sclerosis developed refractory fingolimod-related genital Human Papilloma Virus (HPV) infection. Multiple Sclerosis and Related Disorders. p. 5. ISSN 2211-0348

(2024) Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study. Heliyon. p. 11.

(2024) Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study. Clinical Neurology and Neurosurgery. p. 7. ISSN 0303-8467

(2023) Evaluating the Influential Factors on the Time Interval between the Symptoms Onset and Diagnosis of Patients with Multiple Sclerosis. Multiple Sclerosis Journal. pp. 715-716. ISSN 1352-4585

(2023) Iranian specialists' approach to surgery in patients with multiple sclerosis. Current Journal of Neurology. pp. 96-102. ISSN 2717-011X

(2023) Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment Accepted. Current Journal of Neurology. pp. 1-7. ISSN 2717-011X

(2023) Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics. Multiple Sclerosis and Related Disorders. p. 5. ISSN 2211-0348

(2023) The effect of ginger (<i>Zingiber officinale</i>) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial. Food & Function. pp. 3701-3711. ISSN 2042-6496

(2023) The effect of ginger (Zingiber officinale) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial. Food & Function. pp. 3701-3711. ISSN 2042-650X (Electronic) 2042-6496 (Linking)

(2023) The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial. Bmc Complementary Medicine and Therapies. p. 8.

(2023) The efficacy and safety of ginger supplementation in patients with multiple sclerosis: A rationale and study protocol for a double-blind randomized controlled trial. Health Science Reports. p. 8.

(2022) Characteristics of COVID-19 in patients with multiple sclerosis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Characteristics of COVID-19 in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. p. 103437. ISSN 2211-0356 (Electronic) 2211-0348 (Print) 2211-0348 (Linking)

(2022) Epidemiology of familial multiple sclerosis in Iran: a national registry-based study. BMC NEUROLOGY. ISSN 1471-2377 J9 - BMC NEUROL

(2022) Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. Multiple Sclerosis and Related Disorders. p. 103777. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)